Global United States Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032
The United States Medical Imaging AI market was valued at $1.12B in 2023, projected to reach $10.0B by 2032 at a 27.5% CAGR.
$1.1B
$10.0B
27.5%
North America
Executive Summary
The United States Medical Imaging AI market, valued at USD 1.12 billion in 2023, is projected to reach USD 10.0 billion by 2032, growing at a 27.5% CAGR. Driven by radiologist shortages, rising imaging volumes, and accelerating FDA approvals, the market presents significant investment opportunities across CT, MRI, and radiology application segments.
Key Highlights
US medical imaging AI market valued at USD 1.12 billion in 2023, forecast to reach USD 10.0 billion by 2032.
CT scan and radiology segments dominate, collectively commanding over 53% of total market revenue share in 2023.
Hospitals remain the primary end users, accounting for 45% of market adoption across the United States.
North America holds 40% global market share with the US representing 38% of the regional market.
27.5% CAGR driven by FDA approvals, radiologist shortages, and expanding AI diagnostic applications nationwide.
Market Overview
Market Context
The US medical imaging AI market is in a high-growth phase, propelled by increasing imaging volumes, radiologist shortages, and accelerating regulatory approvals. Cloud-based AI platforms and generative AI tools are reshaping diagnostic workflows across hospitals and imaging centers.
The US medical imaging AI market is experiencing rapid growth, fueled by AI integration in radiology workflows, rising diagnostic demand, and expanding FDA clearances. CT and oncology segments lead adoption, with hospitals as primary end users.
Market Stage
High growth
Adoption Level
Growing
Key Trends
Market Forecast & Data
Base Year (2023)
$1.1B
Forecast (2032)
$10.0B
CAGR (2024-2032)
27.5%
| Year | Market size ($ Billion) |
|---|---|
| 2023Base year | $1.12B |
| 2024 | $1.43B |
| 2025 | $1.82B |
| 2026 | $2.32B |
| 2027 | $2.96B |
| 2028 | $3.77B |
| 2029 | $4.81B |
| 2030 | $6.13B |
| 2031 | $7.82B |
| 2032 | $9.97B |
The market is projected to grow from USD 1.12 billion in 2023 to USD 10.0 billion by 2032 at a 27.5% CAGR. CT scan and radiology applications will continue leading adoption, while cardiology and neurology segments present emerging high-growth opportunities.
| Region | Market share | Growth rate | Largest market |
|---|---|---|---|
| North America | 40.0% | 27.5% | United States |
| Europe | 26.0% | 24.2% | Germany |
| Asia Pacific | 22.0% | 32.1% | China |
| Rest of World | 12.0% | 22.8% | Brazil |
North America
#1Largest market: United States
Europe
#2Largest market: Germany
Market Dynamics
- Rising radiologist shortage and increasing diagnostic imaging volumes
- FDA approvals accelerating AI-powered medical imaging software adoption
- Growing integration of AI in oncology and cardiovascular diagnostics
Market Segmentation
| Segment | Share |
|---|---|
| CT ScanCT scan leads the market due to high AI adoption in detecting pulmonary and abdominal conditions. | 25.0% |
| MRIMRI segment grows rapidly with AI-driven neurology and musculoskeletal imaging applications. | 22.0% |
| X-RayX-ray AI solutions gain traction in emergency departments and primary care screening. | 18.0% |
| UltrasoundUltrasound AI adoption rises in obstetrics, cardiology, and point-of-care settings. | 15.0% |
| PET ScanPET scan AI enhances oncology staging and treatment response monitoring. | 12.0% |
| MammographyMammography AI improves breast cancer screening accuracy and radiologist efficiency. | 8.0% |
| Total | 100.0% |
| Segment | Share |
|---|---|
| RadiologyRadiology dominates as AI automates image reading and triage workflows across hospitals. | 28.0% |
| OncologyOncology applications grow with AI-driven tumor detection, segmentation, and treatment planning. | 24.0% |
| CardiologyCardiology AI enables faster diagnosis of cardiac conditions from CT and MRI scans. | 18.0% |
| NeurologyNeurology AI supports stroke detection, brain tumor analysis, and neurodegenerative disease screening. | 15.0% |
| OrthopedicsOrthopedic AI assists in fracture detection and musculoskeletal imaging interpretation. | 10.0% |
| OthersOther applications include ophthalmology, dermatology, and abdominal imaging AI tools. | 5.0% |
| Total | 100.0% |
By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
- Clinics
Regional Analysis
North America
Lead: United StatesNorth America leads globally driven by advanced healthcare infrastructure and strong AI adoption.
Europe
Lead: GermanyEurope grows steadily with increasing EU regulatory approvals and digital health investments.
Asia Pacific
Lead: ChinaAsia Pacific exhibits the fastest growth, fueled by expanding healthcare access and AI investments.
Rest of World
Lead: BrazilEmerging markets in Latin America and Middle East show growing AI imaging adoption.
Country-Level Analysis
| Country | Share | Growth |
|---|---|---|
| United States | 38.0% | +28.5% |
| Germany | 14.0% | +24.2% |
| China | 18.0% | +32.1% |
Competitive Landscape
Aidoc
Israel
Leading provider of AI-powered radiology solutions with broad FDA clearances across multiple imaging modalities.
Specialized AI radiology company delivering FDA-cleared algorithms for critical finding detection across multiple imaging modalities.
Viz.ai
United States
Fast-growing AI company specializing in stroke and vascular detection with rapid US hospital network expansion.
AI-driven care coordination platform focused on stroke and vascular disease detection with rapid clinical workflow integration.
Arterys
United States
Cloud-native medical imaging AI platform offering FDA-cleared cardiac and lung imaging solutions.
Also profiled
Siemens Healthineers
Global leader in medical imaging equipment integrating AI-powered diagnostic solutions across CT, MRI, and X-ray platforms.
Recent Developments
Received FDA clearance for AI-powered chest X-ray analysis platform expanding thoracic condition detection capabilities.
Expanded AI stroke detection platform to over 1,000 US hospitals strengthening nationwide care coordination networks.
Regulatory Landscape
Research Methodology
Primary research
- Expert interviews
- Surveys
Secondary research
- Industry reports
- Company financials
Validation: Triangulation method
Strategic Takeaways
The market offers high-growth potential driven by regulatory approvals, increasing radiology workloads, and expanding AI integration in diagnostic imaging workflows nationwide.
Adopt scalable AI platforms focusing on CT and radiology applications to capture growing demand from hospitals and diagnostic centers.
Develop standardized AI validation protocols to address regulatory uncertainty and accelerate safe clinical deployment.
Frequently Asked Questions
Related research
Reports in the same field, each with its base-year figure and the growth rate it is published at.
- Medical ImagingGlobal Europe Medical Imaging AI Market$0.9B · 26.5% CAGR
- Medical ImagingGlobal Medical Imaging AI Market$1.4B · 22.5% CAGR
- Medical ImagingGlobal North America Medical Imaging AI Market$1.5B · 24.5% CAGR
- Medical ImagingGlobal Asia Pacific Medical Imaging AI Market$2.4B · 22.5% CAGR
- Medical DevicesGlobal United States Wearable Medical Devices Market$38.5B · 15.4% CAGR
- BiotechnologyGlobal United States Gene Therapy Market$1.4B · 21% CAGR